Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.03M Sell
143,611
-5,989
-4% -$159K 0.52% 36
2025
Q4
$3.73M Sell
149,600
-5,829
-4% -$147K 0.49% 36
2025
Q3
$3.96M Buy
155,429
+990
+0.6% +$24.4K 0.54% 32
2025
Q2
$3.74M Buy
154,439
+7,545
+5% +$176K 0.57% 32
2025
Q1
$3.72M Buy
146,894
+930
+0.6% +$24.3K 0.64% 29
2024
Q4
$3.87M Buy
145,964
+8,937
+7% +$242K 0.64% 27
2024
Q3
$3.97M Buy
137,027
+10,102
+8% +$295K 0.71% 27
2024
Q2
$3.55M Buy
126,925
+15,660
+14% +$431K 0.71% 25
2024
Q1
$3.09M Buy
111,265
+14,731
+15% +$409K 0.7% 29
2023
Q4
$2.78M Buy
96,534
+7,624
+9% +$230K 0.78% 23
2023
Q3
$2.95M Buy
88,910
+8,324
+10% +$294K 0.96% 19
2023
Q2
$2.96M Buy
80,586
+8,152
+11% +$317K 1.04% 16
2023
Q1
$2.96M Sell
72,434
-1,740
-2% -$75.2K 1.28% 15
2022
Q4
$3.8M Buy
74,174
+9,986
+16% +$479K 1.97% 9
2022
Q3
$2.81M Buy
64,188
+4,041
+7% +$196K 1.71% 10
2022
Q2
$3.15M Sell
60,147
-5,600
-9% -$285K 1.95% 8
2022
Q1
$3.4M Sell
65,747
-1,166
-2% -$60.5K 2% 7
2021
Q4
$3.95M Buy
+66,913
New +$3.32M 2.2% 5

Other funds holding PFE

Wahed Invest's PFE Position: Q1 2026 in Review

Wahed Invest reduced its Pfizer (PFE) stake by 4% in Q1 2026, selling an estimated $159K and leaving 143,611 shares worth $4.03M. The position accounts for 0.52% of the portfolio, ranked #36.

Wahed Invest first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wahed Invest held 143,611 shares of Pfizer worth $4.03M as of Q1 2026.
  • Wahed Invest sold 5,989 Pfizer shares in Q1 2026, an estimated $159K.
  • Pfizer made up 0.52% of Wahed Invest's portfolio in Q1 2026, its #36 holding.
  • Wahed Invest first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.